This study was undertaken to test whether ratios between plasma concentrations of different estrogens would be more determinant of prolactin (PRL) secretion than plasma concentrations of estrogens per se have been found to be. Oral administration of micronized 17β-estradiol in a dose of 2 mg b.i.d. for 1 month to 7 postmenopausal women raised plasma estrone (E1) from a median of 29 to 683 pg/ml and plasma 17β-estradiol (E2) from a median of 5.7 to 131 pg/ml. The E1/E2 ratios rose from a median of 4.01 to 4.92 (PWilcoxon (Pw) > 0.025). Basal serum PRL increased from a median of 79.2 to 100 μlU/ml (Pw) > 0.025). However, the area under the curve of the PRL response to TRH increased from a median of 2,553 mm2 before to 3,919 mm2 after treatment (Pw <0.025). Highly significant correlations existed between the E1/E2 ratios and the PRL responses to TRHboth before (rSpearman (rs) = 0.964) (PSpearman (Ps) <0.005) and after (rs = 1.000) (Ps < 0.00025) estradiol treatment, whereas no correlations (Ps <0.679) existed between plasma concentrations of Ei or E2 per se and either basal serum PRL or PRL response to TRH. The regression curves of best fit between the E1/E2 ratios and the PRL responses to TRH were hyperbolic both before (r = 0.884) and after (r = 0.996) treatment. These results, showing that the E1/E2 ratio rather than the plasma Ei or E2 concentrations per se are correlated to the PRL responses to TRH, imply that the metabolic conversion rate of estrogens modulates PRL secretion.